[ALNY] QoQ Quarter Result on 30-Sep-2013 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
07-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- -63.39%
YoY- -52.22%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 7,295 8,275 10,847 8,991 8,687 18,642 8,495 -9.67%
PBT -44,389 -268,813 -29,336 -31,956 -21,053 -9,575 -72,760 -28.13%
Tax -315 -17,870 3,021 -2,270 -2,884 -562 -10,572 -90.45%
NP -44,074 -250,943 -32,357 -29,686 -18,169 -9,013 -62,188 -20.55%
Tax Rate - - - - - - - -
Total Cost 51,369 259,218 43,204 38,677 26,856 27,655 70,683 -19.21%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin -604.17 -3,032.54 -298.30 -330.17 -209.15 -48.35 -732.05 -12.04%
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
EPS -0.58 -3.70 -0.51 -0.48 -0.29 -0.15 -1.20 -38.49%
EPS Diluted -0.58 -3.70 -0.51 -0.48 -0.29 -0.15 -1.20 -38.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.